Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
118.00    -6.00 (-4.84%)
Bid:
116.00
Ask:
120.00
Spread: 4.00 (3.448%)
Market Cap: £70.99m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

US Expansion

12 Dec 2011 07:00

RNS Number : 7450T
Intercede Group PLC
12 December 2011
 



 

 

Intercede Group plc

 

Intercede Continues US Expansion

 

Company Secures E2 Treaty Investor Status

 

 

Leicestershire, England, December 12, 2011 - Intercede Group plc, the developer of the Intercede MyID® Identity and Credential Management System today announces its has been approved as a United States Treaty Investor (E2) by the US Embassy in London.

 

The company is now able to send qualified executives and employees who are UK citizens to work for Intercede MyID Inc., subject only to them meeting the requirements appropriate to E2 status. Intercede MyID Inc is a wholly owned subsidiary of the Intercede Group with offices in Reston, VA.

 

Treaty Investor employees qualify for E-2 work visas. These are non-immigrant visas for nationals of a country with which the United States maintains a treaty of friendship, commerce and navigation who wish to go to the United States to develop and direct the operations of an enterprise in which the Treaty Investor is investing a substantial amount of capital.

 

Richard Parris, Intercede Chairman and Chief Executive said; "I am delighted Intercede has been recognized as an E2 Treaty Investor. This is the result of an extensive application process. We now have the flexibility to more easily outpost key UK staff to our US business in order to accelerate its growth. This will enable Intercede to strengthen its US infrastructure, transfer technology, recruit and train more US staff, extend the Intercede corporate culture to a wider team and provide US opportunities and experiences to our UK staff. I believe this is a key milestone in the corporate development of the Intercede Group and will be instrumental in enabling increased revenues to be generated from the North American market."

 

 

 

ENQUIRIES

 

Intercede Group plc

Tel. +44 (0)1455 558111

Richard Parris, Chairman & Chief Executive

 

Andrew Walker, Finance Director

 

 

 

FinnCap

Tel. +44 (0)20 7600 1658

Charles Cunningham, Corporate Finance

 

Rose Herbert, Corporate Finance

 

Joanna Weaving, Corporate Broking

 

 

Pelham Bell Pottinger

Tel. +44 (0)20 7861 3112

Archie Berens

 

Clare Gilbey

 

 

 

 

 

 

 

About Intercede:

Intercede is the producer of the MyID Identity and Credential Management System and MyID Management Agent for Microsoft Forefront Identity Manager 2010.

 

Intercede MyID technology is being used around the world by large corporations, governments and banks to manage millions of identities for employees, citizens and customers. Notable deployments in the US include 14 federal agencies, two million smart cards in support of the US Transportation Worker Identity Credential program (TWIC), four US financial institutions and 340,000 smart corporate identity badges for Boeing, Booz Allen Hamilton and Lockheed Martin. In Europe, Australasia and the Middle East, Intercede MyID is being deployed in support of government identity, financial services, health and corporate employee ID security projects.

 

Intercede MyID is the only IDCMS software product that enables organizations to easily and securely manage the identities of people and their associated identity credentials within a single, integrated, workflow driven platform. This includes enabling and managing secure registration, biometric capture, application vetting and approval through to smart card personalization, issuance and management.

 

Intercede MyID was the first electronic personalization product to achieve compliance with the US FIPS-201 Personal Identity Verification (PIV) standard and is widely deployed by federal agencies, government contractors and other commercial entities. In particular, it supports the latest standards applicable for all PIV, PIV-Interoperable and PIV-Compatible deployments.

 

It can issue and manage a wide variety of identities and credentials, providing customers with a platform that can meet their needs now and in the future. It is a fully supported commercial off-the-shelf product that can be quickly deployed for thousands or millions of users.

 

For more information contact:

info@intercede.com or visit www.intercede.com or call +44-1455-558111

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUAAARASAUAUA
Date   Source Headline
26th Nov 20247:00 amRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSNotice of Results & Investor Presentation
25th Oct 20247:00 amRNSShare Buyback Programme
11th Oct 20248:38 amRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSTrading Update
1st Oct 20247:00 amRNSNotification of Trading Update and H1 FY25 Results
30th Sep 20247:00 amRNSContract Orders and Renewals
25th Sep 202412:51 pmRNSResult of AGM
20th Sep 202411:45 amRNSDirector/PDMR Shareholding
18th Sep 20247:00 amRNSContract Orders and Renewals
2nd Sep 20247:00 amRNSContract Orders and Subscription Renewals
30th Aug 20247:00 amRNSNotice of AGM and Publication of Annual Report
4th Jul 20243:58 pmRNSIssue of Equity & Total Voting Rights
28th Jun 20243:49 pmRNSIssue of Equity & Total Voting Rights
26th Jun 20247:00 amRNSPartnership with Carahsoft Technology Corp
19th Jun 20246:25 pmRNSHolding(s) in Company
18th Jun 20249:17 amRNSHolding(s) in Company
18th Jun 20247:15 amRNSDirector/PDMR Shareholding and Issue of Equity
18th Jun 20247:00 amRNSFinal Results
5th Jun 20247:00 amRNSNotice of Results & Investor Presentation
16th May 202412:00 pmRNSCapital Markets Day - Agenda Update
14th May 20246:17 pmRNSShare Incentive Scheme
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.